Default Category
-
Altair (A): The Start of a Management Consulting Firm
Martínez, Juan Carlos; Prats, Mª JuliaCase E-147-EEntrepreneurshipOn December 15, 2009, following a long discussion, Juan Carlos Martínez accompanied one of his Advisory Board members to the door. While returning to the office to tidy his desk, he thought about the last words said to him: "Remember what we ended up invoicing in 2008, in the middle of the crisis. You and I both know how hard it was to get there... Of course we can make it happen again." Juan Carlos was definitely thinking along the same lines, b...Starting at €8.20
-
Altair (A): los inicios de una firma de consultoría de dirección
Martínez, Juan Carlos; Prats, Mª JuliaCase E-147EntrepreneurshipEl 15 de diciembre de 2009, Juan Carlos Martínez acompañó a un miembro de su consejo asesor a la puerta y, mientras volvía al despacho para recoger los papeles de la mesa, reflexionó sobre las últimas palabras que, después de un largo rato de debate, le había dicho: "Acuérdate de lo que llegamos a facturar en el 2008, en plena crisis, y tú y yo sabemos que no fue fácil llegar hasta ahí Seguro que esta vez conseguimos darle la vuelta también ". C...Starting at €8.20
-
Dr. Reddy's Laboratories (B)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08M065-EStrategyThis supplement to Dr. Reddy's Laboratories (A), product # 9B08M064, looks at the two years post-acquisition and examines a major risk which, as it unfolded, brought the viability of the business model into question.Starting at €5.74
-
Dr. Reddy's Laboratories (A)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08M064-EStrategyDr. Reddy's Laboratories (Dr. Reddy's), a large pharmaceutical company in India, is trying to acquire the fourth largest generics manufacturer in Germany. Dr. Reddy's quoted $570 million in a competitive bidding situation. The company's chief negotiator is getting ready to close the deal if selected. Students will examine the issues for the chief negotiator, such as: is the price right, is the fit strategic, will the acquisition add value, how ca...Starting at €8.20
-
Altair (B): Resolutely Headed Toward the Future
Martínez, Juan Carlos; Prats, Mª JuliaCase E-148-EEntrepreneurshipJuan Carlos Martínez recalled 2009 as a nightmare. In 2002, together with four other partners, he had set up the strategic consulting firm Altair. From achieving record turnover in 2008, the company went into technical bankruptcy in December 2009, with losses of more than 350,000, few clients and in the final stages of a restructuring process that had left the team diminished and unmotivated - working practically without pay and hoping to see li...Starting at €5.74
-
Altair (B): caminando decididamente hacia el futuro
Martínez, Juan Carlos; Prats, Mª JuliaCase E-148EntrepreneurshipJuan Carlos recordaba el año 2009 como una pesadilla. En el año 2002 había empezado junto con otros cuatro socios la firma de consultoría estratégica Altair. De cifras record de facturación en el año 2008, estaban en diciembre del 2009 en quiebra técnica con pérdidas de más de 350,000 euros, con pocos clientes y terminando una reestructuración que había dejado el equipo menguado, desmotivado y trabajando prácticamente sin cobrar con la esperanza ...Starting at €5.74
-
Dr. Reddy's Laboratories (A) (Spanish version)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08MS64StrategyDr. Reddy's Laboratories (Dr. Reddy's), a large pharmaceutical company in India, is trying to acquire the fourth largest generics manufacturer in Germany. Dr. Reddy's quoted $570 million in a competitive bidding situation. The company's chief negotiator is getting ready to close the deal if selected. Students will examine the issues for the chief negotiator, such as: is the price right, is the fit strategic, will the acquisition add value, how ca...Starting at €8.20
-
Dr. Reddy's Laboratories (B) (Spanish version)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08MS65StrategyThis supplement to Dr. Reddy's Laboratories (A), product # 9B08M064, looks at the two years post-acquisition and examines a major risk which, as it unfolded, brought the viability of the business model into question.Starting at €5.74
-
Schibsted (A): Should We Launch 20 Minutes
Jean-Louis Schaan; Jordan MitchellCase IVEY-9B07M019-EStrategyThe executive vice-president of newspapers for Schibsted was about to meet with his colleagues to discuss the company's plan to release an internally developed free daily newspaper concept called 20 Minutes. Over the past couple of years, Schibsted's executive team had kept a watchful eye on the free newspaper industry, which was enjoying tremendous popularity. Earlier in the year, Schibsted had launched Avis 1, a free paper with direct delivery ...Starting at €8.20